Pennock, Gregory K <br/><br/>
Patient responses to ipilimumab, a novel immunopotentiator for metastatic melanoma: how different are these from conventional treatment responses?  [electronic resource] 

 -  American journal of clinical oncology  Dec 2012 
 - 606-11 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1537-453X 
<br/><br/><label>Standard No.: </label>10.1097/COC.0b013e318209cda9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>CTLA-4 Antigen--antagonists & inhibitors<br/>Humans<br/>Ipilimumab<br/>Melanoma--drug therapy<br/>Skin Neoplasms--drug therapy